PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Sigachi Industries Limited

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Sigachi Industries Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.

What stands out

  • Growth Efficiency Ratio: Sales grew 58% in 3 years, but profit fell: ₹71 less profit per ₹100 of extra sales. Lower than 98% of Healthcare companies in India.
  • Profit Cash Ratio: Over the last 3 years, every ₹100 of reported profit came with ₹-7 of operating cash. Lower than 95% of Healthcare companies in India.
  • Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 94% of Healthcare companies in India.

Where ₹100 of sales goes

₹92Operating costs₹2.7Interest₹17Net loss₹0.8Paid as dividends

Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

₹-7

Over the last 3 years, every ₹100 of reported profit came with ₹-7 of operating cash.

Lower than 95% of Healthcare companies in India.

Self-Funding Ratio

-0.0×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Lower than 91% of Healthcare companies in India.

Cash Locked Ratio

₹48

For every ₹100 of sales, ₹48 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹34 tied up three years earlier.

More money tied up than 89% of Healthcare companies in India.

Growth quality

Steadiness Ratio

2/3 · 2/3

Sales grew in 2 of the last 3 years; profit grew in 2 of 3.

Less steady than 68% of Healthcare companies in India.

Growth Efficiency Ratio

−₹71

Sales grew 58% in 3 years, but profit fell: ₹71 less profit per ₹100 of extra sales.

Lower than 98% of Healthcare companies in India.

Asset Productivity Ratio

+58% / +125%

In 3 years sales changed by +58% while total assets changed by +125%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

-0.3×

Operating cash was negative last year, while some debt falls due within a year.

Lower than 94% of Healthcare companies in India.

Cash Cushion Ratio

−14%

Debt, after subtracting cash, equals 14% of its market value (net debt).

Lower than 84% of Healthcare companies in India.

Tangible Assets Ratio

93%

Of every ₹100 the company owns, ₹93 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 64% of Healthcare companies in India.

Tangible Net Worth Ratio

89%

Of every ₹100 of net worth, ₹89 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

Less tangible than 62% of Healthcare companies in India.

Shareholders

Shareholder Slice Ratio

—

Bonus or split in this period

A bonus issue or share split during these 3 years changed the share count, so older counts are not comparable.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Sigachi Industries Limited owes ₹0.37 for every ₹1 it owns. Sigachi Industries Limited made a loss in the year to Mar 2026, after a profit the year before.

Compared with Healthcare companies in India · latest annual results Mar 2026.

P/E ratio

38.7

Investors pay ₹38.7 for every ₹1 of Sigachi Industries Limited's yearly profit, higher than 54% of Healthcare companies in India.

P/B ratio

1.90

The share price is 1.90 times Sigachi Industries Limited's book value per share, lower than 90% of Healthcare companies in India.

Market cap

₹992 Cr

The total market value of all of Sigachi Industries Limited's shares at today's price (share price × number of shares), smaller than 81% of Healthcare companies in India. PosiCap size class: Micro Cap.

Net worth (book value)

₹522 Cr

What Sigachi Industries Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).

Book value per share

₹13.65

Net worth divided by the number of shares. The share price of ₹25.95 is 1.9 times this, which is the P/B above.

Return on equity (ROE)

5.0%

Sigachi Industries Limited earned 5.0% on its shareholders' money over the last year, lower than 82% of Healthcare companies in India.

Owes vs Owns

0.37×

Sigachi Industries Limited owes ₹0.37 for every ₹1 it owns (low), higher than 50% of Healthcare companies in India.

Dividend yield

None

Sigachi Industries Limited does not currently pay a dividend.

Revenue growth

-2%

Revenue fell 2% in the year to Mar 2026, and grew 17% a year on average over 3 years.

Profit growth

Loss

Sigachi Industries Limited made a loss in the year to Mar 2026, after a profit the year before.

Profit margin

-17.1%

Sigachi Industries Limited lost ₹17 for every ₹100 of revenue.

Interest cover

2.8×

Sigachi Industries Limited's operating profit covered its interest costs 2.8 times in the year to Mar 2026.

Cash vs debt

Net debt

Sigachi Industries Limited had ₹136 Cr more debt than cash (net debt) at Mar 2026.

Questions

What is Sigachi Industries Limited's P/E ratio?

Investors pay ₹38.7 for every ₹1 of Sigachi Industries Limited's yearly profit, higher than 54% of Healthcare companies in India.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Sigachi Industries Limited: ₹992 Cr ÷ ₹522 Cr (31 Mar 2026) = 1.9.

What is Sigachi Industries Limited's return on equity?

Sigachi Industries Limited earned 5.0% on its shareholders' money over the last year, lower than 82% of Healthcare companies in India.

How much does Sigachi Industries Limited owe compared with what it owns?

Sigachi Industries Limited owes ₹0.37 for every ₹1 it owns (low), higher than 50% of Healthcare companies in India.

Does Sigachi Industries Limited pay a dividend?

No. Sigachi Industries Limited does not currently pay a dividend.

Is Sigachi Industries Limited's revenue growing?

Revenue fell 2% in the year to Mar 2026, and grew 17% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.